kyotorphin has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Angelova, H; Dzhambazova, E; Kostadinova, N; Krumova, E; Landzhov, B; Miteva-Staleva, J; Pechlivanova, D | 1 |
| Bardají, E; Castanho, M; Heras, M; Lima, C; Lopes-Ferreira, M; Perazzo, J | 1 |
| Abu Hammad, I; Bachar, T; Grinberg, S; Heldman, E; Linder, C; Popov, M; Stepensky, D | 1 |
| Bardaji, E; Castanho, MA; Conceição, K; Heras, M; Lima, C; Lopes-Ferreira, M; Perazzo, J; Pinto, A; Sá Santos, S; Serrano, I; Tavares, I | 1 |
| Bardaji, E; Castanho, M; Correia, A; Heras, M; Martins, I; Pinto, A; Pinto, M; Ribeiro, MM; Tavares, I | 1 |
| Bocheva, AI; Dzambazova-Maximova, EB | 1 |
7 other study(ies) available for kyotorphin and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Moderate protective effect of Kyotorphin against the late consequences of intracerebroventricular streptozotocin model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anxiety; Brain; Disease Models, Animal; Endorphins; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Wistar; Spatial Memory; Streptozocin; Treatment Outcome | 2019 |
Neuropeptide Kyotorphin Impacts on Lipopolysaccharide-Induced Glucocorticoid-Mediated Inflammatory Response. A Molecular Link to Nociception, Neuroprotection, and Anti-Inflammatory Action.
Topics: Animals; Chemokine CXCL1; Dipeptides; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Disease Models, Animal; Endorphins; Glucocorticoids; Inflammation; Leukocytes; Lipopolysaccharides; Male; Mice; Neuroprotection; Nociception; Peptidyl-Dipeptidase A | 2017 |
Delivery of analgesic peptides to the brain by nano-sized bolaamphiphilic vesicles made of monolayer membranes.
Topics: Analgesics; Animals; Blood-Brain Barrier; Brain; Cations; Chitosan; Cholinesterases; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Endorphins; Enkephalin, Leucine; Furans; Male; Mice; Mice, Inbred ICR; Nanoparticles; Pain; Peptides; Pyridones; Tissue Distribution | 2013 |
Endothelium-Mediated Action of Analogues of the Endogenous Neuropeptide Kyotorphin (Tyrosil-Arginine): Mechanistic Insights from Permeation and Effects on Microcirculation.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Dipeptidases; Disease Models, Animal; Dose-Response Relationship, Drug; Endorphins; Endothelium; Hyperalgesia; Leukocytes; Male; Mice; Microcirculation; Rats; Time Factors | 2016 |
Inhibition of nociceptive responses after systemic administration of amidated kyotorphin.
Topics: Acute Disease; Administration, Oral; Analgesics; Animals; Blood-Brain Barrier; Chronic Disease; Dipeptides; Disease Models, Animal; Endorphins; Injections, Intraperitoneal; Injections, Spinal; Male; Pain; Protein Binding; Rats; Rats, Wistar; Receptors, Opioid | 2011 |
Effects of kyotorphin and analogues on nociception and pentylenetetrazole seizures.
Topics: Analgesics; Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Endorphins; Male; Pain; Pain Measurement; Pentylenetetrazole; Rats; Rats, Wistar; Seizures | 2004 |